Biography
Dr. David Jackman is a medical oncologist at Dana-Farber Cancer Institute and Brigham and Women's Hospital in Boston, where he practices within the Lowe Center for Thoracic Oncology. He specializes in systemic therapy for mesothelioma, working closely with the thoracic surgery team at Brigham and Women's — one of the most established mesothelioma surgical programs in the world. Dr. Jackman completed his medical degree at Brown University and his fellowship at Dana-Farber, and his clinical focus includes chemotherapy, immunotherapy, and clinical trial enrollment for mesothelioma patients.
Education & Training
- Medical Degree — Brown University School of Medicine (Medicine)
- Residency — Brigham and Women's Hospital (Internal Medicine)
- Fellowship — Dana-Farber Cancer Institute (Medical Oncology)
Specialties & Procedures
Clinical Specialties
- Medical Oncology
- Thoracic Oncology
As a medical oncologist, Dr. David Jackman focuses on non-surgical treatment modalities including chemotherapy, immunotherapy, targeted therapy, and clinical trials.
Board Certifications
- American Board of Internal Medicine — Medical Oncology
- American Board of Internal Medicine — Internal Medicine
Research Focus
Systemic therapy for mesothelioma, combination chemotherapy and immunotherapy regimens, and clinical outcomes in pleural mesothelioma.
Legal Resources for Mesothelioma Patients
Patients diagnosed with mesothelioma after asbestos exposure may be eligible for compensation through asbestos trust funds and legal claims. Over $30 billion remains available in trust funds nationwide.
Frequently Asked Questions
What is Dr. Jackman's role in Dana-Farber's mesothelioma program?
Dr. Jackman provides medical oncology care for mesothelioma patients at Dana-Farber, including systemic therapy with chemotherapy and immunotherapy. He works alongside the thoracic surgical team at Brigham and Women's Hospital as part of a comprehensive multidisciplinary program.